Healthcare -
Medical - Care Facilities - NYSE - US
$ 329.63
-0.609 %
$ 81.2 B
Market Cap
14.99
P/E
1. INTRINSIC VALUE
Balance Sheet
HCA Healthcare, Inc.
| Current Assets | 16.4 B |
| Cash & Short-Term Investments | 1.93 B |
| Receivables | 10.8 B |
| Other Current Assets | 3.73 B |
| Non-Current Assets | 43.1 B |
| Long-Term Investments | 1.23 B |
| PP&E | 31.5 B |
| Other Non-Current Assets | 10.3 B |
| Current Liabilities | 15.2 B |
| Accounts Payable | 4.28 B |
| Short-Term Debt | 4.7 B |
| Other Current Liabilities | 6.2 B |
| Non-Current Liabilities | 43.8 B |
| Long-Term Debt | 40.2 B |
| Other Non-Current Liabilities | 3.58 B |
EFFICIENCY
Earnings Waterfall
HCA Healthcare, Inc.
| Revenue | 70.6 B |
| Cost Of Revenue | 0 |
| Gross Profit | 70.6 B |
| Operating Expenses | 66.7 B |
| Operating Income | 3.95 B |
| Other Expenses | -1.81 B |
| Net Income | 5.76 B |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
HCA Healthcare, Inc.
| Net Income | 5.76 B |
| Depreciation & Amortization | 3.31 B |
| Capital Expenditures | -4.88 B |
| Stock-Based Compensation | 360 M |
| Change in Working Capital | -465 M |
| Others | 1.52 B |
| Free Cash Flow | 5.64 B |
Wall Street Analysts Price Targets
HCA Healthcare, Inc.
Wall Street analysts predict an average 1-year price target for HCA of $400 , with forecasts ranging from
a
low of
$329 to a high of $475 .
HCA Lowest Price Target
Wall Street Target
329 USD
-0.19%
HCA Average Price Target
Wall Street Target
400 USD
21.35%
HCA Highest Price Target
Wall Street Target
475 USD
44.10%
4. DIVIDEND
ANALYSIS
0.22%
DIVIDEND YIELD
0.72 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
HCA Healthcare, Inc.
Sold
0-3 MONTHS
3.08 M USD 1
3-6 MONTHS
2.92 M USD 3
6-9 MONTHS
8.27 M USD 5
9-12 MONTHS
5.25 M USD 4
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.com
- 1 week ago
5 Defensive Stocks to Buy for a Safe Portfolio Amid Tariff-Led Mayhem
Five defensive stocks to buy at this soaring volatility are TAP, CNP, WEC, BSX, HCA.
zacks.com
- 1 week ago
HCA Healthcare Named One of the World's Most Admired Companies by Fortune
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it has been named on Fortune's 2025 World's Most Admired Companies list. HCA Healthcare is ranked first overall in its industry. “It is an honor to be named a World's Most Admired Company by Fortune again this year,” said Sam Hazen, CEO of HCA Healthcare. “Recognition on this list underscores our unwavering dedication to our colleagues and patients as we con.
businesswire.com
- 1 week ago
2 Stocks to Buy if You're Worried About a Recession
Is a recession coming? Our economic outlook seems increasingly gloomy due to President Trump's trade policies.
fool.com
- 1 week ago
HCA Healthcare, Inc. 1st Quarter 2025 Earnings Conference Call
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q 2025 Earnings Call When: Friday, April 25, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be.
businesswire.com
- 2 weeks ago
HCA Healthcare: Attractive Even With Medicaid Risk
HCA Healthcare shares have gained 5% over the past year, with potential Medicaid cuts posing a modest future risk to revenue. Despite potential Medicaid cuts, HCA's relatively low Medicaid exposure (11% of revenue) limits the impact to about 0.5% of revenue. HCA's strong financial performance, including $5.6 billion in free cash flow and robust buybacks, supports ongoing capital returns to investors.
seekingalpha.com
- 2 weeks ago
Scoop Up These 3 GARP Stocks to Receive Handsome Returns
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. HCA, NFG and BGC are some such stocks.
zacks.com
- 2 weeks ago
Has HCA Healthcare (HCA) Outpaced Other Medical Stocks This Year?
Here is how HCA Healthcare (HCA) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
zacks.com
- 2 weeks ago
HCA Healthcare Names Monica Cintado as Senior Vice President of Development
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Monica Cintado has been appointed as senior vice president of development, effective immediately. In this role, Cintado will lead HCA Healthcare's enterprise development strategy, overseeing mergers, acquisitions, divestitures and strategic investments. She will also guide market analysis, partnership initiatives and real estate strategies to support HCA Hea.
businesswire.com
- 2 weeks ago
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
zacks.com
- 2 weeks ago
HCA Healthcare Announces $1.84 Million HCA Healthcare Foundation Grant to United Way
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation, through its Healthier Tomorrow Fund, will give $1.84 million to Mile High United Way to launch United for Healthy Starts, a national collaboration between four United Ways to help increase access to social, economic and educational support services for families. The effort is led by Mile High United Way in Denver and includes U.
businesswire.com
- 3 weeks ago
Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.com
- 4 weeks ago
8. Profile
Summary
HCA Healthcare, Inc. HCA
COUNTRY
US
INDUSTRY
Medical - Care Facilities
MARKET CAP
$ 81.2 B
Dividend Yield
0.22%
Description
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Contact
One Park Plaza, Nashville, TN, 37203
https://www.hcahealthcare.com
IPO
Date
March 10, 2011
Employees
226000
Officers
Mr. Michael A. Marks
Chief Financial Officer & Executive Vice President
Ms. Wendy Warren
Senior Vice President, Chief Ethics & Compliance Officer
Mr. Michael R. McAlevey
Executive Vice President and Chief Legal & Administrative Officer
Mr. Christopher F. Wyatt
Senior Vice President, Principal Accounting Officer & Controller
Dr. Thomas F. Frist Jr., M.D.
Founder & Chairman Emeritus
Mr. Jon Mack Foster
Executive Vice President & Chief Operating Officer
Mr. Frank George Morgan C.F.A.
Vice President of Investor Relations
Dr. Michael S. Cuffe M.B.A., M.D.
Executive Vice President & Chief Clinical Officer
Mr. Chad J. Wasserman
Senior Vice President & Chief Information Officer
Mr. Samuel N. Hazen
Chief Executive Officer & Director